Companies in #Melanoma

Found 2 companies operating in this sector.

Huyabio International

Private

Huyabio International is a clinical-stage biopharmaceutical company developing novel small molecule oncology therapeutics. Lead program HBI-8000 (tucidinostat) is an HDAC inhibitor that has demonstrated Phase 3 success in melanoma and is approved in China for multiple oncology indications.

Sector:Oncology / HDAC Inhibitors

HQ:San Diego, California, USA

View Profile →

Replimune

NASDAQ: REPL ↗

Services: Oncolytic immunotherapies, RP1 for anti-PD1 failed melanoma, cancer immunotherapy

Sector:Oncolytic Immunotherapy

HQ:Woburn, MA, USA

View Profile →